Guardant Health Cash Flow Statement (2017-2026) | GH

Cash Flow Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-107.53M-72.31M-123.23M-229.43M-161.99M-139.93M-133.53M-72.77M-86.10M-187.04M-114.98M-102.63M-107.75M-111.01M-95.16M-99.90M-92.72M-128.49M-112.08M-120.14M
Depreciation and Depletion (Quarter)
5.00M5.60M6.70M8.10M9.10M9.50M9.60M9.90M10.30M10.10M10.00M10.10M10.10M9.90M9.80M9.60M9.00M9.70M9.10M9.30M
Share-based Compensation (Quarter)
-46.32M26.86M24.80M25.54M20.64M-66.91M0.99M4.12M61.33M24.32M1.54M3.24M99.26M36.37M15.50M7.42M100.11M-92.49M47.61M57.73M
Deferred Taxes (Quarter)
Gains from Investment Securities (Quarter)
0.97M0.54M2.39M1.42M0.39M0.11M-0.30M0.31M0.22M-0.12M
Asset Writedowns and Impairment (Quarter)
5.26M5.49M23.57M5.00M-5.00M
Cash from Operations (Quarter)
-53.15M-76.99M-28.62M-111.94M-78.16M-90.75M-74.44M-94.02M-77.79M-78.73M-30.28M-94.00M-51.06M-64.51M-62.69M-60.28M-35.41M-26.37M-65.62M-57.78M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-3.02M-3.30M-2.45M-1.35M0.43M-1.23M1.01M2.08M7.83M2.64M-0.11M0.00M2.92M3.96M0.79M6.99M0.99M
Amortization of Deferred Charges (Quarter)
0.64M0.64M0.64M0.64M0.64M0.64M0.64M0.60M0.64M0.64M0.65M0.60M0.60M0.65M
Depreciation & Amortization (CF) (Quarter)
5.54M6.09M7.20M8.79M9.81M10.17M10.35M10.63M11.04M10.87M10.71M10.62M10.60M10.45M10.24M10.04M9.41M10.05M9.44M9.56M
Change in Working Capital
Change in Receivables (Quarter)
7.08M36.91M-13.30M10.94M-9.08M11.06M-12.35M1.65M2.33M-0.02M-4.22M15.96M-12.05M21.70M6.12M14.31M-14.45M22.20M-0.94M6.89M
Change in Inventory (Quarter)
-1.75M5.93M5.94M23.28M3.16M-11.45M-5.12M14.06M16.50M-15.09M1.04M3.99M5.31M-1.21M6.17M6.80M6.43M-4.61M-2.02M21.61M
Change in Account Payables (Quarter)
-0.17M1.70M-0.75M11.84M6.66M
Change in Accured Expenses (Quarter)
3.18M24.31M20.93M1.49M24.29M13.62M13.89M2.63M10.06M-21.39M13.24M-28.27M-4.79M16.99M-1.54M-2.74M3.28M53.74M-8.23M44.29M
Other Working Capital Changes (Quarter)
-2.78M3.92M-21.88M17.58M-0.47M-15.67M-1.76M2.66M1.67M-34.04M5.63M3.03M-7.10M-37.68M3.07M-4.16M0.31M0.57M-1.06M32.80M
Investing Activities
Capital Expenditures (Quarter)
22.15M24.62M22.70M-5.80M-7.99M68.55M8.02M6.02M2.37M-11.13M6.93M5.08M4.20M18.88M4.46M5.65M10.35M-16.35M5.58M11.76M
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)
209.00M325.00M310.00M25.00M63.00M157.00M228.00M264.70M-492.70M1.53M35.00M18.60M307.32M-307.32M954.93M113.23M
Cash from Investing Activities (Quarter)
-47.39M-266.70M110.81M-72.89M41.27M70.63M157.22M-241.13M260.70M663.45M28.07M-5.08M-294.83M10.53M302.86M-10.65M-14.35M-905.07M699.42M101.47M
Financing Activities
Other financing activities (Quarter)
0.01M2.71M0.96M1.20M3.58M-6.88M-0.02M-0.02M5.95M-5.50M0.26M-0.44M7.39M-4.09M-0.00M7.68M-1.63M7.54M-4.48M26.05M
Cash from Financing Activities (Quarter)
-5.56M3.78M-0.01M-172.09M-19.31M2.32M-0.85M383.85M3.81M90.57M-1.07M5.90M-2.88M-2.94M-66.85M1.62M4.33M732.03M-21.58M23.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
90.60M
Additional items
Exchange Rate Effect (Quarter)
-0.11M-0.50M-0.79M-1.42M-0.53M1.14M-0.16M-1.25M-0.53M1.03M-1.14M-0.84M1.90M-1.70M0.77M0.94M-0.53M-0.69M-0.19M-0.41M
Change in Cash (Quarter)
-106.21M-340.40M81.39M-358.33M-56.73M-16.66M81.77M47.46M186.19M676.32M-4.43M-94.02M-346.87M-58.61M174.10M-68.37M-45.97M-200.10M612.02M66.30M
Free Cash Flow (Quarter)
-75.29M-101.61M-51.32M-106.14M-70.17M-159.30M-82.46M-100.04M-80.16M-67.60M-37.22M-99.08M-55.26M-83.39M-67.15M-65.93M-45.76M-10.03M-71.20M-69.54M
Net Cash Flow (Quarter)
-106.10M-339.90M82.18M-356.92M-56.20M-17.80M81.93M48.71M186.72M675.29M-3.29M-93.18M-348.77M-56.92M173.32M-69.31M-45.43M-199.41M612.22M66.71M